-
公开(公告)号:EP3411075A1
公开(公告)日:2018-12-12
申请号:EP17704968.1
申请日:2017-02-03
发明人: VEIBY, Ole Peter , CHARI, Ravi, V. J. , LAMBERT, John M. , LAI, Katharine C. , HERBST, Robert W. , HILDERBRAND, Scott A.
CPC分类号: A61K47/6871 , A61K47/6803 , A61K47/6859 , A61K47/6863 , A61K2039/505 , C07K16/28 , C07K2317/21 , C07K2317/73 , C07K2317/77
摘要: This invention relates to antibody-drug conjugates capable of delivering cytotoxic compounds to cancers expressing the guanylyl cyclase C (GCC) transmembrane cell surface receptor.
-
公开(公告)号:EP3737421A1
公开(公告)日:2020-11-18
申请号:EP19738220.3
申请日:2019-01-11
申请人: Immunogen, Inc.
-
公开(公告)号:EP3188761A1
公开(公告)日:2017-07-12
申请号:EP15837813.3
申请日:2015-09-02
申请人: ImmunoGen, Inc.
IPC分类号: A61K47/64
CPC分类号: A61K47/6803 , A61K47/6849 , A61K47/6851 , A61K2039/505 , A61K2039/545 , C07K16/28 , C07K16/2803 , C07K16/2863 , C07K16/30 , C07K2317/24 , C07K2317/73 , C07K2317/92 , C07K2317/94
摘要: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate ("ADC") that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range.
摘要翻译: 本发明提供了用于配制包含抗体药物偶联物(“ADC”)的治疗组合物的改进方法,所述抗体药物偶联物降低ADC批次之间的效力变异性并且提供了在狭窄的预期范围内施用此类治疗组合物。
-
-